Informations générales (source: ClinicalTrials.gov)
Ultrasound Assessment of Rectus Femoris Cross-sectionnal Area Following Lung Transplantation (EchoSS-TP)
Observational [Patient Registry]
Hopital Foch (Voir sur ClinicalTrials)
mars 2024
mai 2025
07 avril 2025
In France, the profile of patients receiving lung transplants has changed in recent
years, mainly due to the advent of treatment for cystic fibrosis. This progress has led
to an evolution in the patient profile, with an increase in cases of pulmonary fibrosis
or COPD, and an increase in the average age of patients. In these older patients,
sarcopenia, a condition characterized by loss of muscle mass, is a major concern, as it
exacerbates morbidity and mortality.
After transplantation, patients are at risk of developing neuromyopathy due to their
hospitalization in intensive care. There is currently no effective preventive treatment
for this condition, underlining the need for early rehabilitation strategies. The
combination of sarcopenia and neuromyopathy diminishes their functional capabilities on
discharge from the ICU.
Muscle ultrasound, a simple, non-invasive technique, is already used to assess muscle
function in intensive care patients. This study aims to evaluate the use of ultrasound to
measure muscle loss in lung transplant patients, in particular by examining the rectus
femoris muscle. Objectives include observing variations in the surface area of the rectus
femoris muscle before and after transplantation, identifying factors influencing this
variation, and exploring its relationship with post-transplant morbidity.
In summary, this study seeks to better understand muscle loss in lung transplant patients
using ultrasound, in order to identify risk factors and guide the development of
post-transplant rehabilitation strategies.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL FOCH | MATTHIEU REFFIENNA | 05/05/2025 07:12:15 | Contacter | ||
Critères
Tous
Inclusion Criteria:
- Patient over the age of 18
- Patient registered on the lung transplant list at Hôpital Foch for a single or
double-lung transplant
- Patient who did not object to inclusion in the study
- Patient affiliated to a French health insurance plan
- Patient over the age of 18
- Patient registered on the lung transplant list at Hôpital Foch for a single or
double-lung transplant
- Patient who did not object to inclusion in the study
- Patient affiliated to a French health insurance plan
- Patient listed for a combined transplant (heart-lung, liver-lung, lung-kidney)
- Patient on national priority list (super-emergency)
- Pregnant or breast-feeding patient
- Patient under guardianship